Category 'Rulemaking'


Last week, the Obama Administration released the last budget of his presidency, accompanied by a near universal declaration the document was “DOA.” But is it? Included in the thousands of arcane budget pages were Medicare savings totaling half a trillion dollars. Most of the savings – 32 percent – come from prescription drugs, like imposing…

Continue reading →

Those anticipating a quiet year in health policy could be in for a surprise. While many analysts contend that election-year headwinds will prevent legislative progress on a broad range of issues, this year’s Horizon’s Health Policy Outlook offers a contrarian view. We believe the first half of 2016 could be the most productive legislative session…

Continue reading →

Background On January 10, 2014, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule that would have made sweeping changes to the Medicare Part D prescription drug program. On May 19th, CMS released its final rule on Part D. Partly in response to bipartisan Congressional pressure and hundreds of patient, provider, employer…

Continue reading →

Background On January 10, 2014, the Centers for Medicare and Medicaid Services (CMS) issued a 700 page proposed regulation governing contract year 2015 Medicare Advantage (MA) and prescription drug benefit programs. The rule proposes sweeping changes to Parts C and D, and is engendering intense interest from Members of Congress of both parties. Comments on…

Continue reading →

© 2014 HORIZON GOVERNMENT AFFAIRS| 440 1st St. NW, Suite 430 | Washington, DC 20001